A recent study conducted by researchers from Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, and Columbia University reports that SARS-CoV-2 can infect dopamine neurons in the brain, leading to senescence—a state where cells lose the ability to grow and divide. Published in Cell Stem Cell, the findings suggest a potential link between SARS-CoV-2 infection and the neurological symptoms associated with long COVID, such as brain fog, lethargy, and depression.

The research, led by senior author Dr. Shuibing Chen, aimed to explore how various cell types in different organs respond to SARS-CoV-2 infection. Surprisingly, dopamine neurons were found to be uniquely affected, with infected neurons ceasing normal function and releasing chemical signals causing inflammation. Dopamine neurons play a crucial role in functions like pleasure, motivation, memory, sleep, and movement, and their damage is associated with Parkinson's disease.

The researchers used transcriptional profiling to identify how SARS-CoV-2 infection modified gene activity and the resulting changes in the way cells behaved. “We discovered that only dopamine cells had the senescence pathway activated,” said Dr. Chen. In stark contrast, the genes in the senescence pathway were not significantly turned on with SARS-CoV-2 infected lung organoids, pancreatic cells, liver organoids or heart cells.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

The researchers found that the gene signatures from the infected lab-grown dopamine neurons and the dopamine neurons from COVID autopsy samples were the same. This included genes that triggered chemical signals for inflammation.

Next, they looked for ways to protect the neurons to reduce the risk of neurological defects when a patient is infected by the virus.

The researchers tested drugs already marketed for various conditions to find one that either prevented SARS-CoV-2 infection or rescued infected dopamine neurons from senescence.  The screen identified three drugs that blocked SARS-CoV-2 infection thereby preventing the dopamine cells from senescence: riluzole (treats ALS or Lou Gehrig’s disease), metformin (treats diabetes) and imatinib (treats cancer). Further study on these drugs may lead to a way to prevent the virus’s attack on the brain.